Serial 87873334
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Nov 2025)
What this means for you
Registered since 06 Aug 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87873334
- Registration number
- 5824186
- Mark type
- Design / logo
- Filed
- 11 Apr 2018
- Published for opposition
- 21 May 2019
- Registered
- 06 Aug 2019
- Attorney of record
- Jonathan S. Jennings
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 04 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Nov 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Jul 2025 — TEAS SECTION 8 & 15 RECEIVED
- 06 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 21 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 May 2019 — PUBLISHED FOR OPPOSITION
- 01 May 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Apr 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Mar 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Mar 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Mar 2019 — ASSIGNED TO LIE
- 28 Feb 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Aug 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED